ERYTECH Announces the availability of the exemption document relating to the proposed combination with Pherecydes Post author:Cleo Sciscioli Post published:May 23, 2023 Post category:Newsroom You Might Also Like ERYTECH announces management change January 8, 2015 ERYTECH Announces Third DSMB Safety Review and Continuation of Its Phase 2b Study in Acute Myeloid Leukemia January 6, 2016 ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F April 24, 2018
ERYTECH Announces Third DSMB Safety Review and Continuation of Its Phase 2b Study in Acute Myeloid Leukemia January 6, 2016
ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F April 24, 2018
